Vien Lai

Vien Lai has extensive work experience in regulatory and medical writing. From 2023, Vien has worked as a Senior Manager in Regulatory and Medical Writing at Cabaletta Bio. Prior to that, in 2023, Vien also worked as a Consultant at NeuraWell Therapeutics. From 2019 to 2023, Vien held roles at Impel Pharmaceuticals, starting as a Principal Medical Writer and Regulatory Scientist, and later becoming a Principal Medical Writer and Regulatory Manager. Vien's experience also includes working as a Senior Regulatory Writer at Synchrogenix, a Certara company, from 2018 to 2019. Previously, from 2014 to 2018, Vien worked as a Regulatory/Research Scientist at Camargo Pharmaceutical Services. Vien began their career as a Postdoctoral Researcher at the University of Cincinnati from 2009 to 2014.

Vien Lai completed their MD degree at the University of Medicine and Pharmacy, Ho Chi Minh City in 1997. Later, they pursued a PhD in Cardiovascular Sciences at the University of Leicester, which they completed in 2009.